Certified by Founder Lodge
Bicara Therapeutics
United States - Cambridge, Massachusetts
START UP
1 Disclosed Funding Rounds $108,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Bicara Therapeutics is a clinical-stage company developing first-in-class biologics engineered to bring together the precision of targeted therapy and the power of tumor modulators. The compa
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 07 ,2023 | Series B | $108,000,000 | |
| December, 14 ,2023 | Series C | $165,000,000.00 |
Eight Roads
F-Prime Capital
The Invus Group
Omega Funds
Piper Sandler
Janus Henderson Investors
Acorn Bioventures
Bioqube Ventures
Red Tree Venture Capital
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
StratusGrid | $3,000,000 | (Jun 3, 2026)
Mecka | $60,000,000 | (Jun 3, 2026)
Subtle Medical | $33,000,000 | (Jun 3, 2026)
KOSMOS | $5,000,000 | (Jun 3, 2026)
Novellia | $18,000,000 | (Jun 3, 2026)
